| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Positron Emission Tomography Computed Tomography | 23 | 2021 | 1458 | 6.26 | Why? |
| Fluorodeoxyglucose F18 | 19 | 2021 | 1153 | 5.74 | Why? |
| Radiopharmaceuticals | 14 | 2020 | 763 | 3.93 | Why? |
| Whole Body Imaging | 7 | 2020 | 116 | 3.01 | Why? |
| Lymphoma, B-Cell, Marginal Zone | 4 | 2018 | 44 | 2.77 | Why? |
| Iodine Radioisotopes | 4 | 2019 | 124 | 2.04 | Why? |
| Burkitt Lymphoma | 3 | 2019 | 15 | 1.74 | Why? |
| Magnetic Resonance Imaging | 19 | 2020 | 6551 | 1.60 | Why? |
| Talus | 2 | 2017 | 7 | 1.43 | Why? |
| Neoplasms, Second Primary | 3 | 2018 | 100 | 1.30 | Why? |
| Hodgkin Disease | 3 | 2018 | 204 | 1.30 | Why? |
| Thyroid Neoplasms | 4 | 2019 | 422 | 1.19 | Why? |
| Tendinopathy | 3 | 2019 | 18 | 1.09 | Why? |
| Tumor Burden | 3 | 2019 | 369 | 0.98 | Why? |
| Brain Neoplasms | 3 | 2020 | 669 | 0.98 | Why? |
| Lymphoma | 2 | 2018 | 522 | 0.97 | Why? |
| Diffusion Magnetic Resonance Imaging | 3 | 2018 | 317 | 0.89 | Why? |
| Chondrogenesis | 2 | 2017 | 19 | 0.89 | Why? |
| Glycolysis | 2 | 2019 | 208 | 0.88 | Why? |
| Lung Diseases, Interstitial | 3 | 2021 | 1476 | 0.86 | Why? |
| Spinal Neoplasms | 2 | 2019 | 95 | 0.85 | Why? |
| Carcinoma, Papillary | 3 | 2019 | 76 | 0.84 | Why? |
| Incidental Findings | 3 | 2020 | 487 | 0.83 | Why? |
| Bone Neoplasms | 3 | 2019 | 287 | 0.83 | Why? |
| Osteonecrosis | 2 | 2018 | 55 | 0.83 | Why? |
| Contrast Media | 8 | 2019 | 1011 | 0.82 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2019 | 1573 | 0.80 | Why? |
| Single Photon Emission Computed Tomography Computed Tomography | 2 | 2019 | 131 | 0.78 | Why? |
| Rotator Cuff Injuries | 1 | 2019 | 32 | 0.77 | Why? |
| Soft Tissue Neoplasms | 2 | 2017 | 131 | 0.76 | Why? |
| Procarbazine | 1 | 2018 | 14 | 0.76 | Why? |
| Sacroiliac Joint | 1 | 2018 | 26 | 0.74 | Why? |
| Posterior Tibial Tendon Dysfunction | 1 | 2017 | 2 | 0.74 | Why? |
| Spermatocele | 1 | 2017 | 2 | 0.73 | Why? |
| Lymphoma, Mantle-Cell | 1 | 2019 | 109 | 0.73 | Why? |
| Fractures, Stress | 1 | 2017 | 13 | 0.71 | Why? |
| Plasmacytoma | 1 | 2017 | 15 | 0.71 | Why? |
| Injections, Intra-Articular | 2 | 2019 | 104 | 0.71 | Why? |
| Uterine Neoplasms | 1 | 2018 | 70 | 0.70 | Why? |
| Fluorine Radioisotopes | 1 | 2017 | 59 | 0.70 | Why? |
| Cecal Neoplasms | 1 | 2017 | 2 | 0.69 | Why? |
| Adenocarcinoma, Follicular | 1 | 2017 | 21 | 0.69 | Why? |
| Platelet-Rich Plasma | 2 | 2018 | 91 | 0.69 | Why? |
| Cartilage, Articular | 1 | 2017 | 50 | 0.68 | Why? |
| Endometrial Neoplasms | 1 | 2018 | 120 | 0.68 | Why? |
| Histiocytosis, Langerhans-Cell | 1 | 2017 | 46 | 0.68 | Why? |
| Choline | 1 | 2017 | 77 | 0.66 | Why? |
| Stromal Cells | 1 | 2017 | 105 | 0.66 | Why? |
| Ki-67 Antigen | 1 | 2017 | 139 | 0.65 | Why? |
| Biomimetic Materials | 1 | 2017 | 70 | 0.65 | Why? |
| Leiomyoma | 1 | 2017 | 59 | 0.64 | Why? |
| Tissue Scaffolds | 1 | 2017 | 174 | 0.60 | Why? |
| Pituitary Neoplasms | 1 | 2017 | 130 | 0.59 | Why? |
| Radiation Injuries | 1 | 2017 | 140 | 0.58 | Why? |
| Neoplasm Recurrence, Local | 3 | 2019 | 1063 | 0.58 | Why? |
| Adipose Tissue | 2 | 2018 | 612 | 0.58 | Why? |
| Sarcoma | 1 | 2018 | 290 | 0.58 | Why? |
| Neoplasm Metastasis | 1 | 2018 | 682 | 0.57 | Why? |
| Absorptiometry, Photon | 3 | 2020 | 168 | 0.56 | Why? |
| Adenoma | 1 | 2017 | 215 | 0.56 | Why? |
| Radiologists | 2 | 2020 | 873 | 0.55 | Why? |
| Neoplasm Staging | 5 | 2019 | 1999 | 0.54 | Why? |
| Pancreatic Neoplasms | 2 | 2018 | 609 | 0.54 | Why? |
| Cell Differentiation | 2 | 2017 | 1338 | 0.53 | Why? |
| Stem Cell Transplantation | 1 | 2019 | 531 | 0.52 | Why? |
| Gadolinium | 3 | 2017 | 318 | 0.46 | Why? |
| Image Interpretation, Computer-Assisted | 4 | 2019 | 665 | 0.45 | Why? |
| Arthrography | 2 | 2019 | 8 | 0.41 | Why? |
| Tomography, X-Ray Computed | 10 | 2021 | 25144 | 0.39 | Why? |
| Lung Neoplasms | 4 | 2019 | 3228 | 0.37 | Why? |
| Middle Aged | 45 | 2021 | 270681 | 0.37 | Why? |
| Delayed Diagnosis | 1 | 2018 | 1529 | 0.35 | Why? |
| Bone Density | 3 | 2020 | 335 | 0.35 | Why? |
| Biomarkers, Tumor | 1 | 2017 | 1314 | 0.35 | Why? |
| Thyroidectomy | 3 | 2019 | 207 | 0.35 | Why? |
| Aged | 36 | 2021 | 215776 | 0.34 | Why? |
| Bleomycin | 2 | 2018 | 195 | 0.33 | Why? |
| Diagnostic Errors | 3 | 2019 | 865 | 0.33 | Why? |
| Adult | 37 | 2021 | 244371 | 0.33 | Why? |
| Retrospective Studies | 24 | 2021 | 105322 | 0.33 | Why? |
| Ultrasonography | 3 | 2018 | 4409 | 0.32 | Why? |
| Male | 48 | 2021 | 367725 | 0.32 | Why? |
| Prognosis | 10 | 2019 | 32490 | 0.32 | Why? |
| Female | 44 | 2021 | 380317 | 0.31 | Why? |
| Doxorubicin | 2 | 2018 | 313 | 0.30 | Why? |
| Emergencies | 1 | 2020 | 4095 | 0.29 | Why? |
| Kidney Neoplasms | 3 | 2018 | 832 | 0.29 | Why? |
| Aged, 80 and over | 20 | 2020 | 88759 | 0.27 | Why? |
| Humans | 71 | 2021 | 930598 | 0.26 | Why? |
| Reproducibility of Results | 10 | 2019 | 11304 | 0.26 | Why? |
| Nuclear Medicine | 2 | 2020 | 585 | 0.25 | Why? |
| Fractures, Bone | 2 | 2018 | 487 | 0.23 | Why? |
| Postoperative Complications | 2 | 2019 | 5861 | 0.22 | Why? |
| Adolescent | 15 | 2019 | 86841 | 0.22 | Why? |
| Predictive Value of Tests | 5 | 2021 | 9537 | 0.21 | Why? |
| Image Processing, Computer-Assisted | 3 | 2018 | 1383 | 0.21 | Why? |
| Musculoskeletal Diseases | 2 | 2019 | 646 | 0.21 | Why? |
| Meglumine | 1 | 2019 | 26 | 0.21 | Why? |
| Brain | 1 | 2017 | 5133 | 0.20 | Why? |
| Osteoma, Osteoid | 1 | 2019 | 6 | 0.20 | Why? |
| Arthroplasty, Replacement, Ankle | 1 | 2019 | 5 | 0.20 | Why? |
| Hip Injuries | 1 | 2019 | 3 | 0.20 | Why? |
| Femoracetabular Impingement | 1 | 2019 | 4 | 0.20 | Why? |
| Myocardial Bridging | 1 | 2019 | 6 | 0.20 | Why? |
| Surgical Equipment | 1 | 2019 | 37 | 0.20 | Why? |
| Adrenalectomy | 1 | 2019 | 32 | 0.20 | Why? |
| Synovial Fluid | 1 | 2019 | 64 | 0.19 | Why? |
| Combined Modality Therapy | 2 | 2019 | 3395 | 0.19 | Why? |
| Median Nerve | 1 | 2018 | 18 | 0.19 | Why? |
| Connective Tissue | 1 | 2018 | 8 | 0.19 | Why? |
| Patellofemoral Joint | 1 | 2018 | 4 | 0.19 | Why? |
| Posterior Cruciate Ligament | 1 | 2018 | 5 | 0.19 | Why? |
| Follow-Up Studies | 4 | 2019 | 17020 | 0.19 | Why? |
| Patellar Ligament | 1 | 2018 | 8 | 0.19 | Why? |
| Fluoroscopy | 1 | 2019 | 140 | 0.19 | Why? |
| Cancellous Bone | 1 | 2018 | 14 | 0.19 | Why? |
| Early Diagnosis | 2 | 2019 | 2443 | 0.19 | Why? |
| Fractures, Ununited | 1 | 2018 | 5 | 0.19 | Why? |
| Margins of Excision | 1 | 2019 | 122 | 0.19 | Why? |
| Limb Deformities, Congenital | 1 | 2018 | 35 | 0.19 | Why? |
| Hip Joint | 1 | 2019 | 59 | 0.19 | Why? |
| Ethmoid Sinus | 1 | 2018 | 10 | 0.19 | Why? |
| Joint Instability | 1 | 2018 | 20 | 0.19 | Why? |
| Retreatment | 1 | 2019 | 186 | 0.19 | Why? |
| 3-Iodobenzylguanidine | 1 | 2018 | 25 | 0.19 | Why? |
| Cystitis | 1 | 2019 | 45 | 0.19 | Why? |
| Vinblastine | 1 | 2018 | 48 | 0.19 | Why? |
| Flatfoot | 1 | 2017 | 2 | 0.19 | Why? |
| Intervertebral Disc Degeneration | 1 | 2018 | 31 | 0.19 | Why? |
| Adrenal Gland Neoplasms | 1 | 2019 | 70 | 0.18 | Why? |
| Thyroglobulin | 1 | 2018 | 39 | 0.18 | Why? |
| Gadolinium DTPA | 1 | 2018 | 45 | 0.18 | Why? |
| Dacarbazine | 1 | 2018 | 67 | 0.18 | Why? |
| Prostate-Specific Antigen | 1 | 2020 | 213 | 0.18 | Why? |
| Vincristine | 1 | 2018 | 89 | 0.18 | Why? |
| Breast Neoplasms | 1 | 2016 | 3633 | 0.18 | Why? |
| Carpal Tunnel Syndrome | 1 | 2018 | 32 | 0.18 | Why? |
| Diffusion Tensor Imaging | 1 | 2018 | 125 | 0.18 | Why? |
| Tendons | 1 | 2017 | 43 | 0.18 | Why? |
| Osteotomy | 1 | 2017 | 30 | 0.18 | Why? |
| Musculoskeletal System | 1 | 2019 | 78 | 0.18 | Why? |
| Muscle Strength | 1 | 2020 | 317 | 0.18 | Why? |
| Tibia | 1 | 2018 | 72 | 0.18 | Why? |
| Kidney Diseases, Cystic | 1 | 2017 | 30 | 0.18 | Why? |
| Phantoms, Imaging | 1 | 2018 | 146 | 0.18 | Why? |
| Nephrogenic Fibrosing Dermopathy | 1 | 2017 | 7 | 0.18 | Why? |
| Emergency Service, Hospital | 2 | 2020 | 14232 | 0.18 | Why? |
| Tomography, Emission-Computed, Single-Photon | 1 | 2020 | 279 | 0.17 | Why? |
| Achilles Tendon | 1 | 2017 | 26 | 0.17 | Why? |
| Muscles | 1 | 2018 | 152 | 0.17 | Why? |
| Liver Neoplasms | 3 | 2019 | 1666 | 0.17 | Why? |
| Paranasal Sinus Neoplasms | 1 | 2018 | 55 | 0.17 | Why? |
| Resistance Training | 1 | 2020 | 273 | 0.17 | Why? |
| Etoposide | 1 | 2018 | 115 | 0.17 | Why? |
| Glioma | 1 | 2020 | 189 | 0.17 | Why? |
| Orthopedics | 2 | 2020 | 1279 | 0.17 | Why? |
| Organometallic Compounds | 1 | 2019 | 206 | 0.17 | Why? |
| Neovascularization, Physiologic | 1 | 2018 | 160 | 0.17 | Why? |
| Radiology, Interventional | 2 | 2019 | 398 | 0.16 | Why? |
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 112 | 0.16 | Why? |
| Lumbar Vertebrae | 1 | 2018 | 196 | 0.16 | Why? |
| Surgery, Computer-Assisted | 1 | 2019 | 183 | 0.16 | Why? |
| Upper Extremity | 1 | 2019 | 193 | 0.16 | Why? |
| Biological Transport | 1 | 2017 | 290 | 0.16 | Why? |
| Reference Standards | 2 | 2017 | 1163 | 0.16 | Why? |
| Wound Healing | 2 | 2018 | 424 | 0.16 | Why? |
| Injections | 1 | 2017 | 237 | 0.16 | Why? |
| Image Enhancement | 1 | 2018 | 177 | 0.16 | Why? |
| Cyclophosphamide | 1 | 2018 | 387 | 0.16 | Why? |
| Foot | 1 | 2017 | 195 | 0.16 | Why? |
| Transplantation, Autologous | 1 | 2017 | 364 | 0.15 | Why? |
| Fingers | 1 | 2018 | 221 | 0.15 | Why? |
| Radiography, Interventional | 1 | 2017 | 158 | 0.15 | Why? |
| Endometriosis | 1 | 2017 | 130 | 0.15 | Why? |
| Spinal Fractures | 1 | 2017 | 124 | 0.15 | Why? |
| Treatment Outcome | 7 | 2019 | 51732 | 0.15 | Why? |
| Low Back Pain | 1 | 2018 | 190 | 0.15 | Why? |
| Sarcopenia | 1 | 2021 | 422 | 0.15 | Why? |
| Coronary Circulation | 1 | 2017 | 188 | 0.14 | Why? |
| Young Adult | 10 | 2019 | 93724 | 0.14 | Why? |
| Italy | 9 | 2021 | 38444 | 0.14 | Why? |
| Myocardial Perfusion Imaging | 1 | 2017 | 218 | 0.14 | Why? |
| Feasibility Studies | 3 | 2019 | 3467 | 0.14 | Why? |
| Chest Pain | 1 | 2019 | 578 | 0.14 | Why? |
| Positron-Emission Tomography | 1 | 2020 | 802 | 0.14 | Why? |
| Ultrasonography, Interventional | 1 | 2019 | 560 | 0.13 | Why? |
| Pain Measurement | 1 | 2017 | 533 | 0.13 | Why? |
| Analysis of Variance | 1 | 2017 | 950 | 0.13 | Why? |
| Professional Competence | 1 | 2017 | 246 | 0.13 | Why? |
| Prednisone | 1 | 2018 | 652 | 0.13 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.13 | Why? |
| Diagnosis, Differential | 5 | 2019 | 7220 | 0.13 | Why? |
| Liver | 2 | 2018 | 4007 | 0.13 | Why? |
| Hospital Departments | 1 | 2020 | 831 | 0.12 | Why? |
| Radiography | 2 | 2017 | 1576 | 0.12 | Why? |
| Healthy Volunteers | 1 | 2018 | 1444 | 0.12 | Why? |
| Lower Extremity | 1 | 2017 | 593 | 0.12 | Why? |
| Magnetic Resonance Spectroscopy | 1 | 2017 | 881 | 0.12 | Why? |
| Carcinoma, Hepatocellular | 2 | 2019 | 1222 | 0.11 | Why? |
| Carcinoma, Renal Cell | 1 | 2018 | 545 | 0.11 | Why? |
| Preoperative Care | 2 | 2019 | 1515 | 0.11 | Why? |
| Membrane Glycoproteins | 1 | 2020 | 2273 | 0.11 | Why? |
| Adenocarcinoma | 1 | 2017 | 651 | 0.10 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 13720 | 0.10 | Why? |
| Acetabulum | 2 | 2019 | 18 | 0.10 | Why? |
| Radiology | 1 | 2021 | 1199 | 0.10 | Why? |
| ROC Curve | 2 | 2018 | 6024 | 0.10 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.09 | Why? |
| Diagnostic Imaging | 1 | 2017 | 1044 | 0.09 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.09 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.09 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.09 | Why? |
| Crohn Disease | 1 | 2017 | 959 | 0.09 | Why? |
| Child, Preschool | 5 | 2018 | 36283 | 0.09 | Why? |
| Debridement | 2 | 2019 | 172 | 0.08 | Why? |
| Laparoscopy | 1 | 2019 | 1532 | 0.08 | Why? |
| Clinical Protocols | 1 | 2019 | 2734 | 0.08 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.08 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.08 | Why? |
| Rheumatology | 1 | 2017 | 1213 | 0.08 | Why? |
| Tissue Distribution | 2 | 2018 | 483 | 0.08 | Why? |
| Risk | 1 | 2018 | 5288 | 0.07 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.07 | Why? |
| Prostatic Neoplasms | 1 | 2017 | 1637 | 0.07 | Why? |
| Survival Rate | 1 | 2019 | 9206 | 0.07 | Why? |
| Surveys and Questionnaires | 3 | 2021 | 43792 | 0.07 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.07 | Why? |
| Radiography, Thoracic | 1 | 2021 | 5486 | 0.07 | Why? |
| Sensitivity and Specificity | 3 | 2018 | 22971 | 0.06 | Why? |
| Child | 5 | 2018 | 70012 | 0.06 | Why? |
| Coronary Artery Disease | 1 | 2017 | 2570 | 0.06 | Why? |
| Densitometry | 1 | 2020 | 40 | 0.05 | Why? |
| Fibrocartilage | 1 | 2019 | 1 | 0.05 | Why? |
| Femur Neck | 1 | 2019 | 29 | 0.05 | Why? |
| Joint Prosthesis | 1 | 2019 | 20 | 0.05 | Why? |
| Rupture | 1 | 2019 | 40 | 0.05 | Why? |
| Biopsy | 2 | 2019 | 2811 | 0.05 | Why? |
| Ankle Joint | 1 | 2019 | 42 | 0.05 | Why? |
| Arthroscopy | 1 | 2019 | 46 | 0.05 | Why? |
| Neoplasm, Residual | 1 | 2019 | 147 | 0.05 | Why? |
| Red Meat | 1 | 2018 | 39 | 0.05 | Why? |
| Neck Dissection | 1 | 2019 | 109 | 0.05 | Why? |
| Thoracic Surgery, Video-Assisted | 1 | 2019 | 97 | 0.05 | Why? |
| Echo-Planar Imaging | 1 | 2017 | 27 | 0.04 | Why? |
| Nitrogen Radioisotopes | 1 | 2017 | 8 | 0.04 | Why? |
| Angiography | 1 | 2019 | 301 | 0.04 | Why? |
| Metabolic Clearance Rate | 1 | 2017 | 110 | 0.04 | Why? |
| Organ Size | 1 | 2018 | 384 | 0.04 | Why? |
| Operative Time | 1 | 2019 | 450 | 0.04 | Why? |
| Ammonia | 1 | 2017 | 61 | 0.04 | Why? |
| Glioblastoma | 1 | 2020 | 187 | 0.04 | Why? |
| Body Composition | 1 | 2020 | 414 | 0.04 | Why? |
| Intraoperative Complications | 1 | 2019 | 221 | 0.04 | Why? |
| Postoperative Period | 1 | 2019 | 651 | 0.04 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.04 | Why? |
| Fracture Fixation | 1 | 2018 | 128 | 0.04 | Why? |
| Artifacts | 1 | 2018 | 250 | 0.04 | Why? |
| In Vitro Techniques | 1 | 2019 | 1027 | 0.04 | Why? |
| Neoplasm Grading | 1 | 2017 | 400 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.04 | Why? |
| Multimodal Imaging | 1 | 2020 | 534 | 0.04 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.04 | Why? |
| Observer Variation | 1 | 2017 | 622 | 0.04 | Why? |
| Fractional Flow Reserve, Myocardial | 1 | 2017 | 173 | 0.04 | Why? |
| Spine | 1 | 2017 | 292 | 0.03 | Why? |
| Comorbidity | 1 | 2019 | 34796 | 0.03 | Why? |
| Quality Control | 1 | 2018 | 628 | 0.03 | Why? |
| Muscle, Skeletal | 1 | 2021 | 915 | 0.03 | Why? |
| Imaging, Three-Dimensional | 1 | 2019 | 680 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Severity of Illness Index | 2 | 2019 | 48226 | 0.03 | Why? |
| Surgical Wound Infection | 1 | 2018 | 501 | 0.03 | Why? |
| Societies, Medical | 2 | 2019 | 6907 | 0.03 | Why? |
| Coronary Vessels | 1 | 2019 | 914 | 0.03 | Why? |
| Lung | 1 | 2020 | 31049 | 0.03 | Why? |
| Neoplasms | 1 | 2020 | 17251 | 0.03 | Why? |
| Safety | 1 | 2019 | 1583 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Coronary Angiography | 1 | 2019 | 2275 | 0.02 | Why? |
| Computed Tomography Angiography | 1 | 2019 | 2153 | 0.02 | Why? |
| Recurrence | 1 | 2018 | 3675 | 0.02 | Why? |
| Health Care Surveys | 1 | 2017 | 2942 | 0.02 | Why? |
| Hemorrhage | 1 | 2019 | 3013 | 0.02 | Why? |
| Mesenchymal Stem Cell Transplantation | 1 | 2018 | 1322 | 0.02 | Why? |
| Liver Cirrhosis | 1 | 2018 | 1810 | 0.02 | Why? |
| Kidney Diseases | 1 | 2017 | 1434 | 0.02 | Why? |
| Patient Selection | 1 | 2019 | 4560 | 0.02 | Why? |
| Kidney | 1 | 2017 | 3648 | 0.02 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.01 | Why? |
| Communicable Disease Control | 2 | 2021 | 29620 | 0.01 | Why? |
| Length of Stay | 1 | 2019 | 11042 | 0.01 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.01 | Why? |
| Infant | 1 | 2018 | 30274 | 0.01 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |